Trade & Investment Agency

D-Heart biomedical start-up was founded in 2015 thanks to the work of Nicolò Briante and Niccolò Maurizi, at the time two young students in the interdisciplinary environment of the Almo Collegio Borromeo of Pavia. Maurizi is a young doctor researcher in cardiology at the University of Florence. When he was sixteen, Maurizi was hit by a myocardial infarction. He decided to became a doctor and transform his problem into an opportunity. Thanks to the help and business expertise of his roommate, Briante, they created D-Heart, the first smartphone ECG device that combines the usability required by the patient and reliability of the ECG wanted by the doctor. What limited the diffusion of homecare ECG devices up to now, was that to obtain reliable information for the doctors, cumbersome and unfriendly devices had to be used. Particularly, challenging cable uncoiling and the placement of electrodes in specific points were the main challenges. D-Heart, thanks to its innovative yet easy proprietary technology, solves both these problems: the user can wind up all the cables at once, or one at a time, and in any order, with intuitive positioning given by the cable exit direction from the device. D-Heart app also shows the patient’s own chest with electrodes placed to aid further simplicity and reliability. The result is to have a device as reliable as the one present in your doctor’s office always with you ready to be simply used. The user can rely on the 24/7 tele-cardiology service to get results quickly from our trusted cardiologists. The device comes in a protective case with a wireless charging station. Everything from the device, app and packaging is designed and share the same design principle that reflects the D-Heart brand: simplicity meets reliability.